Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant

Journal of Infectious Diseases

Volumn 203, Issue 6, 2011, Pages 870-879

  Srikram, Amporn ^a,b   Zhang, Kunkun ^c   Bartpho, Thanatchaporn ^a   Lo, Miranda ^c   Hoke, David E ^c   Sermswan, Rasana W ^a   Adler, Ben ^c   Murray, Gerald L ^c  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KASETSART UNIVERSITY   (Thailand)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIN; BACTERIUM LIPOPOLYSACCHARIDE; INACTIVATED VACCINE; LIVE VACCINE; M 1352; MUTANT PROTEIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN A; OUTER MEMBRANE PROTEIN LIPL32; PROTEIN G; PROTEIN LA1939; PROTEIN LA2372; PROTEIN LA3961; PROTEIN LIGA; PROTEIN LIPL36; PROTEIN LIPL41; PROTEIN LOA22; PROTEIN OMPL36; SECRETORY PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS PROTECTION; HAMSTER; IMMUNOSTIMULATION; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; SEROTYPE; SURVIVAL RATE; TRANSPOSON;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CRICETINAE; CROSS REACTIONS; CYTOKINES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MESOCRICETUS; MUTATION; VACCINES, ATTENUATED;

EID: 79952344765     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq127     Document Type: Article

References (45)

1. Adler B, de la Pena Moctezuma A. Leptospira and leptospirosis. Vet Microbiol 2010; 140:287-96.
2. McBride AJ, Athanazio DA, Reis MG, Ko AI. Leptospirosis. Curr Opin Infect Dis 2005; 18:376-86.
3. Bolin CA, Alt DP. Use of a monovalent leptospiral vaccine to prevent renal colonization and urinary shedding in cattle exposed to Leptospira borgpetersenii serovar Hardjo. Am J Vet Res 2001; 62:995-1000. (Pubitemid 32601294)
4. Feigin RD, Lobes LA Jr, Anderson D, Pickering L. Human leptospirosis from immunized dogs. Ann Intern Med 1973; 79:777-85.
5. Haake DA, Mazel MK, McCoy AM, et al. Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun 1999; 67:6572-82.
6. Silva EF, Medeiros MA, McBride AJ, et al. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 2007; 25:6277-86. (Pubitemid 47088033)
7. Bulach DM, Zuerner RL, Wilson P, et al. Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc Natl Acad Sci U S A 2006; 103:14560-5. (Pubitemid 44484789)
8. Nascimento AL, Ko AI, Martins EA, et al. Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J Bacteriol 2004; 186:2164-72. (Pubitemid 38381206)
9. Picardeau M, Bulach DM, Bouchier C, et al. Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS One 2008; 3:e1607.
10. Ren SX, Fu G, Jiang XG, et al. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 2003; 422:888-93. (Pubitemid 36520040)
11. Bourhy P, Louvel H, Saint Girons I, Picardeau M. Random insertional mutagenesis of Leptospira interrogans, the agent of leptospirosis, using a mariner transposon. J Bacteriol 2005; 187:3255-8. (Pubitemid 40571619)
12. Murray GL, Ellis KM, Lo M, Adler B. Leptospira interrogans requires a functional heme oxygenase to scavenge iron from hemoglobin. Microbes and Infection 2008; 10:791-7.
13. Murray GL, Morel V, Cerqueira GM, et al. Genome-wide transposon mutagenesis in pathogenic Leptospira species. Infect Immun 2009; 77:810-6.
14. Murray GL, Srikram A, Henry R, Puapairoj A, Sermswan RW, Adler B. Leptospira interrogans requires heme oxygenase for disease pathogenesis. Microbes Infect 2009; 11:311-4.
15. Murray GL, Srikram A, Hoke DE, et al. Major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans. Infect Immun 2009; 77:952-8.
16. Ristow P, Bourhy P, da Cruz McBride FW, et al. The OmpA-like protein Loa22 is essential for leptospiral virulence. PLoS Pathog 2007; 3:e97.
17. Murray GL, Srikram A, Henry R, Hartskeerl RA, Sermswan RW, Adler B. Mutations affecting Leptospira interrogans lipopolysaccharide attenuate virulence. Mol Microbiol 2010; 78:701-9.
18. Srikram A, Wongratanacheewin S, Puapairoj A, Wuthiekanun V, Sermswan RW. Analyses of vaccination protocols for Leptospira interrogans serovar Autumnalis in hamsters. Am J Trop Med Hyg 2008; 79:779-86.
19. Jittimanee J, Sermswan RW, Puapairoj A, Maleewong W, Wongratanacheewin S. Cytokine expression in hamsters experimentally infected with Opisthorchis viverrini. Parasite Immunol 2007; 29:159-67. (Pubitemid 46239265)
20. Matsunaga J, Lo M, Bulach DM, Zuerner RL, Adler B, Haake DA. Response of Leptospira interrogans to physiologic osmolarity: relevance in signaling the environment-to-host transition. Infect Immun 2007; 75:2864-74. (Pubitemid 46870167)
21. Imin N, Kerim T, Weinman JJ, Rolfe BG. Characterisation of rice anther proteins expressed at the young microspore stage. Proteomics 2001; 1:1149-61. (Pubitemid 33696480)
22. Hoke DE, Egan S, Cullen PA, Adler B. LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata. Infect Immun 2008; 76:2063-9. (Pubitemid 351656139)
23. Cullen PA, Xu X, Matsunaga J, et al. Surfaceome of Leptospira spp. Infect Immun 2005; 73:4853-63.
24. Im JG, Yeon KM, Han MC, et al. Leptospirosis of the lung: radiographic findings in 58 patients. AJR Am J Roentgenol 1989; 152:955-9. (Pubitemid 19125120)
25. Zaki SR, Shieh WJ. Leptospirosis associated with outbreak of acute febrile illness and pulmonary haemorrhage, Nicaragua, 1995. The Epidemic Working Group at Ministry of Health in Nicaragua. Lancet 1996; 347:535-6.
26. Adler B, Faine S. Host immunological mechanisms in the resistance of mice to leptospiral infections. Infect Immun 1977; 17:67-72. (Pubitemid 8130627)
27. Adler B, Faine S. Susceptibility of mice treated with cyclophosphamide to lethal infection with Leptospira interrogans serovar Pomona. Infect Immun 1976; 14:703-8.
28. Adler B, Faine S. The antibodies involved in the human immune response to leptospiral infection. J Med Microbiol 1978; 11: 387-400.
29. Adler B, Faine S. Immunogenicity of boiled compared with formalized leptospiral vaccines in rabbits, hamsters and humans. J Hyg (Lond) 1980; 84:1-10. (Pubitemid 10211868)
30. Hubbert WT, Miller JN. Studies on immunity in experimental leptospirosis: the immunogenicity of Leptospira icterohemorrhagiae attenuated by gamma-irradiation. J Immunol 1965; 95:759-64.
31. Kenzy SG, Gillespie RW, Lee JH. Comparison of Leptospira pomona bacterin and attenuated live culture vaccine for control of abortion in cattle. J Am Vet Med Assoc 1961; 139:452-4.
32. Fish NA, Kingscote B. Protection of gilts against leptospirosis by use of a live vaccine. Can Vet J 1973; 14:12-5.
33. Stalheim OH. Vaccination against leptospirosis: protection of hamsters and swine against renal leptospirosis by killed but intact gamma-irradiated or dihydrostreptomycin-exposed Leptospira pomona. Am J Vet Res 1967; 28:1671-6.
34. Babudieri B, Castelli M, Pisoni F. Comparative tests with formolized and irradiated vaccines against leptospirosis. Bull World Health Organ 1973; 48:587-90.
35. Cullen PA, Cordwell SJ, Bulach DM, Haake DA, Adler B. Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect Immun 2002; 70:2311-8. (Pubitemid 34408370)
36. Nally JE, Whitelegge JP, Bassilian S, Blanco DR, Lovett MA. Characterization of the outer membrane proteome of Leptospira interrogans expressed during acute lethal infection. Infect Immun 2007; 75:766-73. (Pubitemid 46203439)
37. Hauk P, Macedo F, Romero EC, et al. In LipL32, the major leptospiral lipoprotein, the C-terminus is the primary immunogenic domain and mediates interaction with collagen IV and plasma fibronectin. Infect Immun 2008; 75:2642-50.
38. Guerreiro H, Croda J, Flannery B, et al. Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans. Infect Immun 2001; 69:4958-68. (Pubitemid 32674479)
39. Barnett JK, Barnett D, Bolin CA, et al. Expression and distribution of leptospiral outer membrane components during renal infection of hamsters. Infect Immun 1999; 67:853-61. (Pubitemid 29059228)
40. Koizumi N, Watanabe H. Molecular cloning and characterization of a novel leptospiral lipoprotein with OmpA domain. FEMS Microbiol Lett 2003; 226:215-9. (Pubitemid 38444943)
41. Gamberini M, Gomez RM, Atzingen MV, et al. Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis. FEMS Microbiol Lett 2005; 244:305-13. (Pubitemid 40342843)
42. Pinne M, Haake DA. A comprehensive approach to identification of surface-exposed, outer membrane-spanning proteins of Leptospira interrogans. PLoS One 2009; 4:e6071.
43. Pinne M, Choy HA, Haake DA. The OmpL37 surface-exposed protein is expressed by pathogenic Leptospira during infection and binds skin and vascular elastin. PLoS Negl Trop Dis 2010; 4:e815.
44. Matsunaga J, Barocchi MA, Croda J, et al. Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol 2003; 49:929-45. (Pubitemid 36981340)
45. Matsunaga J, Sanchez Y, Xu X, Haake DA. Osmolarity, a key environmental signal controlling expression of leptospiral proteins LigA and LigB and the extracellular release of LigA. Infect Immun 2005; 73:70-8. (Pubitemid 40041098)